Mohamed Javad Wahadat

6PUBLICATIONS
9CO-AUTHORS
AutoimmunityCardiology (incl. cardiovascular diseases)Gene expression (incl. microarray and other genome-wide approaches)Instrumental methods (excl. immunological and bioassay methods)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 23, 2025
Anti-mitochondrial antibodies as markers of disease activity in childhood-onset systemic lupus erythematosus: a longitudinal cohort study.

Marina Barguil Macêdo, Mohamed Javad Wahadat, Albin Björk

|Sep 06, 2024
Learning from serum markers reflecting endothelial activation: longitudinal data in childhood-onset systemic lupus erythematosus.

Sandy C Bergkamp, Nick D Bergkamp, Mohamed Javad Wahadat

|Apr 03, 2023
Targeted multiomics in childhood-onset SLE reveal distinct biological phenotypes associated with disease activity: results from an explorative study.

Mohamed Javad Wahadat, Sander J van Tilburg, Yvonne M Mueller

|Dec 14, 2022
Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort.

M Javad Wahadat, Hongchao Qi, Cornelia G van Helden-Meeuwsen

|Feb 10, 2022
Gene signature fingerprints stratify SLE patients in groups with similar biological disease profiles: a multicentre longitudinal study.

M Javad Wahadat, Dieneke Schonenberg-Meinema, Cornelia G van Helden-Meeuwsen

|Dec 31, 2021
LLDAS is an attainable treat-to-target goal in childhood-onset SLE.

Mohamed Javad Wahadat, Lotte van den Berg, Demi Timmermans

Pageof 1